Sayenko Kharenko – legal counsel on obtaining merger clearance for acquisition of a leader on Russian market of pharmaceuticals

Sayenko Kharenko’s antitrust team has provided legal assistance in merger clearance with the Antimonopoly Committee of Ukraine (the "AMC") for the EUR 165 million acquisition of Ivonton Holdings Limited ("Ivonton") by Valeant Pharmaceuticals International, Inc. ("Valeant"), a holding company of the Valeant group of companies.

The acquisition will enable Valeant to increase its presence on Russian market of pharmaceuticals.

Ivonton is a holding company of Natur Produkt group, a leader on Russian market of pharmaceuticals.

Valeant is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. 

After the review of the proposed transaction, the AMC concluded that its implementation neither poses threats to competition nor significantly limits competition on any product market in Ukraine.

Sayenko Kharenko's competition team for the current transaction included counsel Dmitry Taranyk and associates Maksym Nazarenko and Yulia Kuyda, and was led by partner Vladimir Sayenko.

Related projects

24 January 2023


Sayenko Kharenko advises Goldman Sachs Asset Management on the acquisition of Cprime
23 January 2023


Sayenko Kharenko advises EBRD on EUR 25 million loan to the city of Lviv
12 January 2023


Sayenko Kharenko advised on the USD 895 million consent solicitation by Ukrainian Railways
Notification cookies

We use cookies to analyze the behavior of visitors
of our website and improve it. By using our website, you consent to these cookies in accordance with our Cookie Policy.